These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12534407)

  • 21. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor.
    Harewood GC; Gostout CJ
    Gastrointest Endosc; 2003 Oct; 58(4):493-9. PubMed ID: 14520279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis.
    Khuroo MS; Khuroo MS; Farahat KL; Kagevi IE
    J Gastroenterol Hepatol; 2005 Jan; 20(1):11-25. PubMed ID: 15610441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of intravenous proton pump inhibitors in high-risk bleeders.
    van Zanten SV
    Can J Gastroenterol; 2004 Dec; 18(12):749-50. PubMed ID: 15605141
    [No Abstract]   [Full Text] [Related]  

  • 25. Should every patient with suspected upper GI bleeding receive a proton pump inhibitor while awaiting endoscopy?
    Barkun AN
    Gastrointest Endosc; 2008 Jun; 67(7):1064-6. PubMed ID: 18513549
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
    Tseng GY; Fang CT; Lin HJ; Yang HB; Tseng GC; Wang PC; Liao PC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2009 Aug; 30(4):406-13. PubMed ID: 19485981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-endoscopic PPI therapy reduces recurrent adverse outcomes in acute non-variceal upper gastrointestinal bleeding.
    Lin HJ
    Aliment Pharmacol Ther; 2007 Feb; 25(3):343-4; author reply 344-5. PubMed ID: 17217451
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of infusion or low-dose proton pump inhibitor treatments in upper gastrointestinal system bleeding.
    Songür Y; Balkarli A; Acartürk G; Senol A
    Eur J Intern Med; 2011 Apr; 22(2):200-4. PubMed ID: 21402254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic Doppler ultrasound versus endoscopic stigmata-directed management of acute peptic ulcer hemorrhage: a multimodel cost analysis.
    Chen VK; Wong RC
    Dig Dis Sci; 2007 Jan; 52(1):149-60. PubMed ID: 17109216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The short-term medical management of non-variceal upper gastrointestinal bleeding.
    Kovacs TO; Jensen DM
    Drugs; 2008; 68(15):2105-11. PubMed ID: 18840002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.
    Enns R; Andrews CN; Fishman M; Hahn M; Atkinson K; Kwan P; Levy A
    Can J Gastroenterol; 2004 Sep; 18(9):567-71. PubMed ID: 15457296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
    Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
    Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention.
    Saini SD; Fendrick AM; Scheiman JM
    Aliment Pharmacol Ther; 2011 Jul; 34(2):243-51. PubMed ID: 21615437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
    Barkun AN; Adam V; Martel M; Bardou M
    Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding.
    Rattanasupar A; Sengmanee S
    J Med Assoc Thai; 2016 Sep; 99(9):988-95. PubMed ID: 29927201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitors for upper gastrointestinal bleeding.
    Kherad O; Restellini S; Martel M; Barkun A
    Best Pract Res Clin Gastroenterol; 2019; 42-43():101609. PubMed ID: 31785730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Octreotide Added to a Proton Pump Inhibitor Versus a Proton Pump Inhibitor Alone in Nonvariceal Upper-Gastrointestinal Bleeds.
    Riha HM; Wilkinson R; Twilla J; Harris LJ; Kimmons LA; Kocak M; Van Berkel MA
    Ann Pharmacother; 2019 Aug; 53(8):794-800. PubMed ID: 30803243
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.